Summary
Glioblastoma (GBM), a formidable brain cancer, has remained a clinical challenge with limited therapeutic progress despite numerous clinical trials and advancements in tumor biology. The landscape of interventional trials in glioblastoma, with over 1,250 registered trials...
More information & hyperlinks
Web resources: | https://www.mdc-berlin.de/gargiulo |